Largest Drug Manufacturers - Specialty & Generic Companies by Market Cap
The Drug Manufacturers - Specialty & Generic sector has 623 publicly listed stocks with a combined market cap of $1.18 Trillion. Takeda Pharmaceutical Co Ltd ADR leads the sector with a market cap of $52.60 Billion. This ranking covers all Drug Manufacturers - Specialty & Generic stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
$52.60 Billion | $52.60 Billion | USA | $16.65 | +0.30% | -6.72% | 71.71 Million |
| 2 |
Zoetis Inc
NYSE:ZTS |
$50.31 Billion | $50.31 Billion | USA | $114.16 | -0.70% | -1.64% | 69.76 Million |
| 3 |
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
$50.29 Billion | CN¥343.70 Billion | China | CN¥53.88 | -2.02% | -2.81% | 1.60 Billion |
| 4 |
GALDERMA GROUP AG
NYSE:GALDY |
$45.88 Billion | $45.88 Billion | USA | $42.09 | +0.55% | +3.64% | 3.02 Million |
| 5 |
Haleon plc
NYSE:HLN |
$41.77 Billion | $41.77 Billion | USA | $9.38 | +1.52% | -1.57% | 169.07 Million |
| 6 |
Takeda Pharmaceutical Company Limited
F:TKDA |
$38.58 Billion | €33.00 Billion | Germany | €13.80 | -0.72% | -4.17% | 34.00 |
| 7 |
Galderma Group N
SW:GALD |
$37.01 Billion | CHF29.28 Billion | Switzerland | CHF163.80 | +2.89% | +8.66% | 12.13 Million |
| 8 |
Sandoz Group AG
SW:SDZ |
$29.43 Billion | CHF23.27 Billion | Switzerland | CHF62.54 | +2.09% | -0.79% | 18.31 Million |
| 9 |
Teva Pharmaceutical Industries Limited
F:TEV |
$24.98 Billion | €21.37 Billion | Germany | €26.20 | -4.73% | +5.22% | 27.57K |
| 10 |
HANSOH PHARMAC. HD-00001
F:3KY |
$23.69 Billion | €20.26 Billion | Germany | €4.00 | +0.91% | -5.86% | 3.60K |
| 11 |
United Therapeutics Corporation
NASDAQ:UTHR |
$21.42 Billion | $21.42 Billion | USA | $570.40 | -0.17% | -0.43% | 12.05 Million |
| 12 |
Viatris Inc
NASDAQ:VTRS |
$17.32 Billion | $17.32 Billion | USA | $15.04 | +0.67% | +1.97% | 209.36 Million |
| 13 |
MERCK KGAA NAM.SP.ADR
F:MRKC |
$17.07 Billion | €14.60 Billion | Germany | €22.60 | -2.59% | -1.74% | 1.20K |
| 14 |
Merck KGaA
XETRA:MRK |
$16.63 Billion | €14.22 Billion | Germany | €110.05 | +1.71% | -4.80% | 8.18 Million |
| 15 |
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
$15.91 Billion | Skr147.87 Billion | Sweden | Skr427.80 | +1.86% | +5.32% | 9.13 Million |
| 16 |
Zhejiang Nhu Co Ltd
SHE:002001 |
$15.65 Billion | CN¥106.96 Billion | China | CN¥34.80 | -0.46% | +1.75% | 1.08 Billion |
| 17 |
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
$15.32 Billion | Rs1.42 Trillion | India | Rs4185.10 | -1.10% | +2.46% | 9.70 Million |
| 18 |
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
$14.40 Billion | $14.40 Billion | USA | $29.12 | -0.34% | +2.86% | 3.73 Million |
| 19 |
Yunnan Baiyao Group Co Ltd
SHE:000538 |
$13.85 Billion | CN¥94.66 Billion | China | CN¥53.05 | -2.89% | -2.62% | 181.20 Million |
| 20 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
$13.03 Billion | $13.03 Billion | USA | $131.78 | +0.08% | +1.22% | 27.09 Million |
| 21 |
IPSEN SA SP.ADR 1/4/ EO 1
F:I7G0 |
$12.92 Billion | €11.05 Billion | Germany | €40.80 | +3.03% | +0.00% | 3.43K |
| 22 |
Cipla Limited
NSE:CIPLA |
$11.44 Billion | Rs1.06 Trillion | India | Rs1309.60 | -0.61% | +5.93% | 49.30 Million |
| 23 |
Lupin Limited
NSE:LUPIN |
$11.39 Billion | Rs1.05 Trillion | India | Rs2305.20 | -0.27% | -0.12% | 27.13 Million |
| 24 |
Elanco Animal Health
NYSE:ELAN |
$11.24 Billion | $11.24 Billion | USA | $22.51 | +0.63% | +0.54% | 86.83 Million |
| 25 |
Dr. Reddy’s Laboratories Ltd ADR
NYSE:RDY |
$11.16 Billion | $11.16 Billion | USA | $13.58 | +5.76% | +4.95% | 58.86 Million |
| 26 |
Ipsen SA
PA:IPN |
$10.50 Billion | €8.98 Billion | France | €167.00 | +2.52% | +4.31% | 3.01 Million |
| 27 |
Dr. Reddy's Laboratories Limited
F:RDDA |
$10.43 Billion | €8.92 Billion | Germany | €11.60 | -1.69% | +8.41% | 60.00 |
| 28 |
Mankind Pharma Ltd
NSE:MANKIND |
$10.03 Billion | Rs927.45 Billion | India | Rs2246.70 | -0.45% | +0.52% | 12.17 Million |
| 29 |
Zydus Lifesciences Limited
NSE:ZYDUSLIFE |
$9.71 Billion | Rs897.46 Billion | India | Rs891.90 | -2.08% | -4.09% | 18.06 Million |
| 30 |
Aurobindo Pharma Limited
NSE:AUROPHARMA |
$8.73 Billion | Rs807.02 Billion | India | Rs1389.50 | -0.52% | -2.23% | 38.94 Million |
| 31 |
Krka d. d
WAR:KRK |
$8.59 Billion | zł31.21 Billion | Poland | zł1022.00 | +0.39% | -0.78% | 1.60K |
| 32 |
Huadong Medicine Co Ltd
SHE:000963 |
$8.56 Billion | CN¥58.50 Billion | China | CN¥33.35 | -0.57% | -2.37% | 309.41 Million |
| 33 |
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294 |
$8.37 Billion | CN¥57.18 Billion | China | CN¥51.29 | -1.18% | -10.16% | 328.30 Million |
| 34 |
Shanghai Fosun Pharmaceutical Group Co Ltd
SHG:600196 |
$7.72 Billion | CN¥52.73 Billion | China | CN¥24.89 | -1.54% | -2.74% | 496.42 Million |
| 35 |
Alkem Laboratories Limited
NSE:ALKEM |
$6.98 Billion | Rs645.65 Billion | India | Rs5400.00 | +1.05% | -4.03% | 3.11 Million |
| 36 |
Laurus Labs Limited
NSE:LAURUSLABS |
$6.43 Billion | Rs594.36 Billion | India | Rs1100.95 | -0.47% | +0.44% | 45.37 Million |
| 37 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
$6.31 Billion | CN¥43.12 Billion | China | CN¥25.91 | -0.58% | -5.37% | 330.38 Million |
| 38 |
Abbott India Limited
NSE:ABBOTINDIA |
$5.85 Billion | Rs540.48 Billion | India | Rs25435.00 | -0.16% | +0.06% | 313.05K |
| 39 |
Beijing Tongrentang Co Ltd
SHG:600085 |
$5.57 Billion | CN¥38.09 Billion | China | CN¥27.77 | +1.39% | +0.54% | 142.80 Million |
| 40 |
H Lundbeck A/S
CO:HLUN-B |
$5.26 Billion | Dkr33.63 Billion | Denmark | Dkr42.40 | -1.12% | -1.90% | 16.18 Million |
| 41 |
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
$5.18 Billion | CN¥35.42 Billion | China | CN¥55.00 | +0.36% | +4.92% | 175.11 Million |
| 42 |
Changchun High & New Technology Industries Group Inc
SHE:000661 |
$5.07 Billion | CN¥34.65 Billion | China | CN¥84.93 | -0.62% | -2.45% | 98.70 Million |
| 43 |
Alkermes plc
F:8AK |
$5.00 Billion | €4.28 Billion | Germany | €28.32 | -1.77% | +0.21% | 282.00 |
| 44 |
Lantheus Holdings Inc
NASDAQ:LNTH |
$4.93 Billion | $4.93 Billion | USA | $85.50 | +1.04% | +3.24% | 15.71 Million |
| 45 |
Alkermes Plc
NASDAQ:ALKS |
$4.62 Billion | $4.62 Billion | USA | $33.38 | -0.98% | -1.56% | 56.26 Million |
| 46 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
$4.58 Billion | €3.92 Billion | Germany | €36.20 | +3.84% | -0.82% | 7.09K |
| 47 |
Yuhan Corp.
KO:000100 |
$4.57 Billion | ₩6.74 Trillion | Korea | ₩91600.00 | -1.72% | -3.68% | 4.67 Million |
| 48 |
Humanwell Healthcare Group Co Ltd
SHG:600079 |
$4.51 Billion | CN¥30.82 Billion | China | CN¥18.88 | -1.72% | +1.12% | 251.34 Million |
| 49 |
Suven Pharmaceuticals Limited
NSE:SUVENPHAR |
$4.40 Billion | Rs406.97 Billion | India | Rs1063.80 | +4.50% | +5.37% | 6.68 Million |
| 50 |
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
$4.17 Billion | CN¥28.47 Billion | China | CN¥17.04 | +0.41% | +3.34% | 373.47 Million |
| 51 |
Hanmi Pharm Co Ltd
KO:128940 |
$3.95 Billion | ₩5.83 Trillion | Korea | ₩460000.00 | -4.76% | -6.98% | 2.00 Million |
| 52 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
$3.91 Billion | $3.91 Billion | USA | $37.66 | +2.39% | +13.57% | 42.27 Million |
| 53 |
SIMCERE PHARMAC. GRP LTD
F:S2P |
$3.85 Billion | €3.30 Billion | Germany | €1.27 | +0.00% | -4.51% | 1.00K |
| 54 |
Ajanta Pharma Limited
NSE:AJANTPHARM |
$3.81 Billion | Rs352.66 Billion | India | Rs2822.70 | +0.66% | +1.57% | 1.92 Million |
| 55 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX |
$3.81 Billion | $3.81 Billion | USA | $12.83 | -0.31% | +1.42% | 35.37 Million |
| 56 |
Laboratorios Farmaceuticos ROVI
MC:ROVI |
$3.81 Billion | €3.26 Billion | Spain | €79.40 | +0.95% | -6.97% | 2.44 Million |
| 57 |
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
$3.73 Billion | CN¥25.51 Billion | China | CN¥27.69 | +0.62% | +11.29% | 143.96 Million |
| 58 |
Siegfried Holding Ltd
SW:SFZN |
$3.71 Billion | CHF2.94 Billion | Switzerland | CHF78.70 | +1.48% | -2.84% | 2.02 Million |
| 59 |
Hims Hers Health Inc
NYSE:HIMS |
$3.71 Billion | $3.71 Billion | USA | $27.41 | +0.88% | -2.63% | 742.61 Million |
| 60 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
$3.57 Billion | $3.57 Billion | USA | $12.18 | +2.01% | -2.72% | 43.40 Million |
| 61 |
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
$3.57 Billion | CN¥24.39 Billion | China | CN¥16.29 | +1.81% | +0.00% | 671.60 Million |
| 62 |
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM |
$3.55 Billion | Rs328.02 Billion | India | Rs2043.40 | -0.86% | +3.32% | 7.55 Million |
| 63 |
INDIVIOR PLC DL 050
F:2IVB |
$3.51 Billion | €3.01 Billion | Germany | €27.00 | -1.53% | -0.74% | 1.51K |
| 64 |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766 |
$3.49 Billion | CN¥23.84 Billion | China | CN¥24.67 | +3.14% | +3.96% | 462.72 Million |
| 65 |
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
$3.46 Billion | CN¥23.65 Billion | China | CN¥1.71 | -1.16% | -1.72% | 3.89 Billion |
| 66 |
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
$3.44 Billion | Rs318.53 Billion | India | Rs1680.10 | -2.88% | +5.14% | 8.54 Million |
| 67 |
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
$3.39 Billion | CN¥23.15 Billion | China | CN¥40.60 | +1.60% | +0.22% | 85.92 Million |
| 68 |
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
$3.33 Billion | CN¥22.77 Billion | China | CN¥22.42 | +0.04% | +4.33% | 245.99 Million |
| 69 |
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
$3.32 Billion | CN¥22.69 Billion | China | CN¥24.63 | -1.00% | -7.89% | 321.29 Million |
| 70 |
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
$3.31 Billion | CN¥22.60 Billion | China | CN¥15.13 | -0.39% | +7.30% | 283.75 Million |
| 71 |
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623 |
$3.30 Billion | CN¥22.57 Billion | China | CN¥18.87 | +1.07% | +4.08% | 252.91 Million |
| 72 |
Aspen Pharmacare Holdings Ltd
JSE:APN |
$3.28 Billion | ZAC6.17 Trillion | South Africa | ZAC13900.00 | -1.16% | +7.00% | 27.12 Million |
| 73 |
Betta Pharmaceuticals Co Ltd
SHE:300558 |
$3.20 Billion | CN¥21.85 Billion | China | CN¥51.94 | +7.83% | +17.59% | 273.91 Million |
| 74 |
Gland Pharma Limited
NSE:GLAND |
$3.12 Billion | Rs288.46 Billion | India | Rs1750.80 | +0.67% | -2.77% | 2.33 Million |
| 75 |
Apeloa Pharmaceutical Co Ltd
SHE:000739 |
$3.10 Billion | CN¥21.16 Billion | China | CN¥18.27 | -1.08% | -0.71% | 228.72 Million |
| 76 |
Walvax BioTech
SHE:300142 |
$3.04 Billion | CN¥20.79 Billion | China | CN¥13.00 | +0.85% | +5.86% | 1.16 Billion |
| 77 |
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU |
$2.95 Billion | €2.52 Billion | Germany | €6.90 | +4.55% | +0.73% | 240.00 |
| 78 |
Wedge Industrial Co Ltd
SHE:000534 |
$2.95 Billion | CN¥20.14 Billion | China | CN¥39.53 | -2.87% | -7.40% | 601.45 Million |
| 79 |
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380 |
$2.93 Billion | CN¥20.00 Billion | China | CN¥10.93 | -1.53% | -0.09% | 346.34 Million |
| 80 |
Hypera S.A
SA:HYPE3 |
$2.83 Billion | R$14.41 Billion | Brazil | R$22.53 | -0.88% | -2.04% | 80.10 Million |
| 81 |
Livzon Pharmaceutical Group Inc
SHE:000513 |
$2.81 Billion | CN¥19.20 Billion | China | CN¥32.65 | -0.55% | -3.12% | 134.87 Million |
| 82 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
$2.74 Billion | $2.74 Billion | USA | $47.85 | -0.31% | -5.04% | 11.64 Million |
| 83 |
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
$2.74 Billion | CN¥18.72 Billion | China | CN¥41.45 | +4.09% | +16.20% | 492.13 Million |
| 84 |
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
$2.73 Billion | CN¥18.68 Billion | China | CN¥117.30 | +0.42% | +0.17% | 273.50 Million |
| 85 |
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
$2.71 Billion | CN¥18.54 Billion | China | CN¥17.85 | -0.61% | -1.54% | 225.59 Million |
| 86 |
Hybio Pharmaceutical
SHE:300199 |
$2.68 Billion | CN¥18.32 Billion | China | CN¥20.74 | -1.14% | -8.11% | 1.31 Billion |
| 87 |
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
$2.65 Billion | CN¥18.08 Billion | China | CN¥9.23 | -3.45% | -6.86% | 2.03 Billion |
| 88 |
Almirall S.A.
MC:ALM |
$2.63 Billion | €2.25 Billion | Spain | €12.58 | +1.29% | -1.87% | 2.98 Million |
| 89 |
Prestige Brand Holdings Inc
NYSE:PBH |
$2.61 Billion | $2.61 Billion | USA | $55.09 | -2.18% | -4.64% | 11.65 Million |
| 90 |
Wanbangde Pharmaceutical Holding Group Co Ltd
SHE:002082 |
$2.55 Billion | CN¥17.43 Billion | China | CN¥28.49 | +0.00% | +1.17% | 1.22 Billion |
| 91 |
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
$2.51 Billion | CN¥17.17 Billion | China | CN¥16.28 | -1.39% | -0.91% | 134.48 Million |
| 92 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
$2.50 Billion | $2.50 Billion | USA | $55.27 | +2.77% | +28.39% | 18.98 Million |
| 93 |
Wockhardt Limited
NSE:WOCKPHARMA |
$2.45 Billion | Rs226.77 Billion | India | Rs1395.60 | +0.28% | -3.77% | 18.08 Million |
| 94 |
Dermapharm Holding SE
XETRA:DMP |
$2.32 Billion | €1.98 Billion | Germany | €46.35 | +0.65% | +1.31% | 706.70K |
| 95 |
Piramal Pharma Limited
NSE:PPLPHARMA |
$2.32 Billion | Rs214.21 Billion | India | Rs161.87 | +1.07% | +5.24% | 146.17 Million |
| 96 |
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
$2.31 Billion | CN¥15.81 Billion | China | CN¥74.56 | +2.40% | -3.53% | 100.44 Million |
| 97 |
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601 |
$2.30 Billion | CN¥15.75 Billion | China | CN¥14.10 | -0.49% | -3.95% | 315.25 Million |
| 98 |
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
$2.30 Billion | CN¥15.73 Billion | China | CN¥16.95 | +4.57% | +3.73% | 568.93 Million |
| 99 |
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
$2.29 Billion | CN¥15.63 Billion | China | CN¥18.39 | -0.16% | +0.22% | 720.34 Million |
| 100 |
Curaleaf Holdings Inc.
TO:CURA |
$2.23 Billion | CA$3.09 Billion | Canada | CA$4.59 | -3.77% | +14.75% | 26.52 Million |
| 101 |
Jiangzhong Pharmaceutical Co Ltd
SHG:600750 |
$2.22 Billion | CN¥15.20 Billion | China | CN¥23.92 | -0.25% | -12.86% | 139.29 Million |
| 102 |
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SHG:603707 |
$2.17 Billion | CN¥14.83 Billion | China | CN¥9.18 | -2.75% | -2.65% | 271.41 Million |
| 103 |
HUTCHMED (China) Limited
F:H7T1 |
$2.15 Billion | €1.84 Billion | Germany | €11.20 | -0.88% | -8.20% | 7.84K |
| 104 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
$2.12 Billion | $2.12 Billion | USA | $21.64 | +0.05% | +0.28% | 72.66 Million |
| 105 |
Natco Pharma Limited
NSE:NATCOPHARM |
$2.12 Billion | Rs196.26 Billion | India | Rs1095.75 | +0.20% | +2.31% | 19.82 Million |
| 106 |
Neuland Laboratories Limited
NSE:NEULANDLAB |
$2.08 Billion | Rs192.49 Billion | India | Rs15003.00 | +2.37% | -0.42% | 978.24K |
| 107 |
Bausch Health Companies Inc
TO:BHC |
$2.06 Billion | CA$2.84 Billion | Canada | CA$7.67 | -1.54% | +1.05% | 7.95 Million |
| 108 |
Zhejiang Medicine Co Ltd
SHG:600216 |
$2.05 Billion | CN¥13.98 Billion | China | CN¥14.54 | -1.09% | -0.34% | 674.46 Million |
| 109 |
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
$2.01 Billion | CN¥13.77 Billion | China | CN¥62.46 | -4.35% | +23.68% | 1.50 Billion |
| 110 |
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
$1.99 Billion | CN¥13.57 Billion | China | CN¥11.32 | -1.31% | -0.44% | 714.71 Million |
| 111 |
Shenzhen Hepalink Pharmaceutical Co Ltd
SHE:002399 |
$1.98 Billion | CN¥13.56 Billion | China | CN¥10.87 | +0.93% | -1.90% | 102.03 Million |
| 112 |
Guobang Pharma Ltd
SHG:605507 |
$1.96 Billion | CN¥13.37 Billion | China | CN¥23.92 | -1.24% | -0.87% | 97.49 Million |
| 113 |
Eris Lifesciences Limited
NSE:ERIS |
$1.95 Billion | Rs180.20 Billion | India | Rs1322.90 | +0.51% | -2.21% | 3.17 Million |
| 114 |
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
$1.91 Billion | CN¥13.04 Billion | China | CN¥40.46 | -1.77% | -2.18% | 71.18 Million |
| 115 |
Shanghai Shyndec Pharmaceutical Co Ltd
SHG:600420 |
$1.88 Billion | CN¥12.86 Billion | China | CN¥9.59 | -0.10% | -1.74% | 278.74 Million |
| 116 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
$1.87 Billion | $1.87 Billion | USA | $9.19 | +0.33% | +4.91% | 92.51 Million |
| 117 |
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
$1.87 Billion | CN¥12.77 Billion | China | CN¥31.32 | +5.35% | +0.97% | 249.30 Million |
| 118 |
Zhejiang Jingxin Pharmaceutical Co Ltd
SHE:002020 |
$1.86 Billion | CN¥12.73 Billion | China | CN¥14.78 | -1.07% | -2.89% | 327.87 Million |
| 119 |
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285 |
$1.86 Billion | CN¥12.68 Billion | China | CN¥22.36 | -0.89% | +3.90% | 186.34 Million |
| 120 |
Lotus Pharmaceutical Co Ltd
TW:1795 |
$1.83 Billion | NT$58.08 Billion | Taiwan | NT$221.00 | +0.23% | -2.43% | 60.30 Million |
| 121 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
$1.80 Billion | $1.80 Billion | USA | $80.39 | +1.18% | +2.98% | 7.48 Million |
| 122 |
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263 |
$1.80 Billion | CN¥12.28 Billion | China | CN¥28.85 | +0.70% | -2.73% | 111.43 Million |
| 123 |
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
$1.79 Billion | CN¥12.27 Billion | China | CN¥13.79 | -1.22% | -18.60% | 436.88 Million |
| 124 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
$1.77 Billion | $1.77 Billion | USA | $16.01 | +0.06% | -7.56% | 26.83 Million |
| 125 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
$1.76 Billion | $1.76 Billion | USA | $15.50 | +0.00% | +0.10% | 76.22 Million |
| 126 |
Porton Fine Chemicals Ltd
SHE:300363 |
$1.69 Billion | CN¥11.53 Billion | China | CN¥21.21 | -0.33% | -3.68% | 350.56 Million |
| 127 |
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
$1.67 Billion | CN¥11.44 Billion | China | CN¥55.35 | +0.73% | +2.33% | 137.06 Million |
| 128 |
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572 |
$1.66 Billion | CN¥11.36 Billion | China | CN¥4.48 | +0.22% | -2.61% | 2.00 Billion |
| 129 |
Celltrion Pharm Inc
KQ:068760 |
$1.65 Billion | ₩2.44 Trillion | Korea | ₩56100.00 | -2.77% | -2.26% | 1.65 Million |
| 130 |
Fagron NV
BR:FAGR |
$1.65 Billion | €1.41 Billion | Belgium | €24.00 | +0.00% | +0.42% | 3.14 Million |
| 131 |
Mayinglong Pharmaceutical Group Co Ltd
SHG:600993 |
$1.64 Billion | CN¥11.22 Billion | China | CN¥26.03 | -0.31% | +4.45% | 83.33 Million |
| 132 |
Perrigo Company PLC
NYSE:PRGO |
$1.64 Billion | $1.64 Billion | USA | $11.92 | +0.68% | +1.97% | 59.76 Million |
| 133 |
BORA PHARMACEUTICALS LTD
TW:6472 |
$1.63 Billion | NT$51.81 Billion | Taiwan | NT$408.00 | -2.16% | -2.63% | 18.97 Million |
| 134 |
Hanall Biopharma
KO:009420 |
$1.63 Billion | ₩2.41 Trillion | Korea | ₩47400.00 | -4.24% | -1.76% | 9.82 Million |
| 135 |
Alembic Pharmaceuticals Limited
NSE:APLLTD |
$1.60 Billion | Rs148.41 Billion | India | Rs755.00 | -0.80% | -1.26% | 2.79 Million |
| 136 |
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
$1.59 Billion | Rs146.75 Billion | India | Rs926.60 | -0.03% | -0.15% | 4.31 Million |
| 137 |
CONSUN PHARMAC.GR.HD -10
F:C1P |
$1.57 Billion | €1.34 Billion | Germany | €1.70 | +1.80% | +2.41% | 2.76K |
| 138 |
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675 |
$1.57 Billion | CN¥10.71 Billion | China | CN¥12.99 | -2.48% | -6.81% | 646.00 Million |
| 139 |
Harrow Health Inc
NASDAQ:HROW |
$1.51 Billion | $1.51 Billion | USA | $40.90 | +0.91% | +5.55% | 11.60 Million |
| 140 |
Perrigo Company plc
F:PIG |
$1.51 Billion | €1.30 Billion | Germany | €9.48 | -2.35% | -4.17% | 1.17K |
| 141 |
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
$1.50 Billion | CN¥10.27 Billion | China | CN¥3.42 | -0.29% | +0.29% | 1.16 Billion |
| 142 |
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099 |
$1.50 Billion | CN¥10.26 Billion | China | CN¥6.34 | -3.65% | -10.07% | 707.11 Million |
| 143 |
Faes Farma SA
MC:FAE |
$1.50 Billion | €1.28 Billion | Spain | €4.86 | +2.53% | -0.92% | 3.07 Million |
| 144 |
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089 |
$1.45 Billion | CN¥9.88 Billion | China | CN¥20.59 | +0.49% | -8.29% | 91.68 Million |
| 145 |
PharmaBlock Sciences Nanjing Inc Class A
SHE:300725 |
$1.36 Billion | CN¥9.32 Billion | China | CN¥39.85 | -0.40% | +2.28% | 205.29 Million |
| 146 |
SHANG.FOS.PHARM.GR.H YC 1
F:08HH |
$1.32 Billion | €1.13 Billion | Germany | €2.05 | -2.52% | -4.15% | 5.55K |
| 147 |
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
$1.32 Billion | CN¥9.02 Billion | China | CN¥3.58 | -2.72% | -8.91% | 4.57 Billion |
| 148 |
Hunan Er Kang Pharmaceutical
SHE:300267 |
$1.32 Billion | CN¥8.99 Billion | China | CN¥4.36 | +3.81% | +6.34% | 2.38 Billion |
| 149 |
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC |
$1.31 Billion | TL58.56 Billion | Turkey | TL85.45 | -0.12% | -3.06% | 173.38 Million |
| 150 |
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
$1.31 Billion | CN¥8.96 Billion | China | CN¥7.00 | -1.27% | -8.62% | 671.38 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - Specialty & Generic industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - specialty & generic corporations. View all industries